<DOC>
	<DOCNO>NCT02643498</DOCNO>
	<brief_summary>The purpose study find maximum dose SBRT safely give chemotherapy treatment pancreatic cancer remove surgically .</brief_summary>
	<brief_title>A Dose Escalation Trial Stereotactic Body Radiotherapy ( SBRT ) After Induction Chemotherapy Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Histologically cytopathologically confirm adenocarcinoma pancreas . Locally advanced , unresectable pancreatic cancer confirm multidisciplinary input hepatobiliary surgeon define CT tumor abutment &gt; 180° ( &gt; 50 % ) circumference superior mesenteric artery ( SMA ) celiac axis , unreconstructable superior mesenteric vein ( SMV ) PV involvement . No evidence distant metastasis either prior induction chemotherapy . Completion least 3 month , 6 month standard induction chemotherapy LAPC , may include FOLFIRINOX gemcitabine nabpaclitaxel , preferably within 24 week longer 8 week . Pancreatic tumor size ≤ 5 cm . Age ≥18 year ECOG 01 . Patients must acceptable organ marrow function define : Leukocytes &gt; 3,000/uL Absolute neutrophil count &gt; 1,500/uL Platelets &gt; 50,000/uL Total bilirubin Within 2 x upper limit normal AST ( SGOT ) /ALT ( SGPT ) &lt; 2.5 x institutional upper limit normal CreatinineCreatinine clearance Within 1.5 x upper limit normal OR &gt; 60 mL/min patient creatinine level institutional normal Ability understand follow breathing instruction involve respiratory gating procedure tolerate compression sufficient reduce fiducial motion ≤ 5mm Ability understand willingness sign write informed consent document . Patients prior abdominal radiotherapy . Patients receive investigational agent Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Contraindication Magnetic Resonance Imaging Patients iodine contrast contraindicate Pregnant breastfeed woman exclude . Women childbearing potential unwilling unable use acceptable method birth control avoid pregnancy entire study period 4 week study exclude . This apply woman experience menarche undergone successful surgical sterilization postmenopausal ( define amenorrhea least 12 consecutive month , woman hormone replacement therapy serum FSH level great 35 mIU/mL . A negative urine serum pregnancy test must obtain within 14 day prior start study therapy woman childbearing potential . Male subject must also agree use effective contraception period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Stereotactic Body Radiotherapy ( SBRT )</keyword>
	<keyword>15-109</keyword>
</DOC>